SABCS 2024 Insights: Impact of Prior Treatment, ESR1 Mutations, and PI3K Pathway on Elacestrant Outcomes in HR /HER2- Advanced Breast Cancer
SABCS 2024 Insights: Impact of Prior Treatment, ESR1 Mutations, …
191 viewsDec 17, 2024
vumedi.com
Dr Lloyd on the Effects of ESR1 Mutations on Elacestrant Outcomes in HR Advanced Breast Cancer
Dr Lloyd on the Effects of ESR1 Mutations on Elacestrant Outcom…
Dec 13, 2024
onclive.com
The EMERALD Trial: Elacestrant in Patients with HR , HER2- Advanced Breast Cancer | OncLive
The EMERALD Trial: Elacestrant in Patients with HR , HER2- Advance…
Feb 9, 2024
onclive.com
Dr Kaklamani on the Effects of VAF on Elacestrant Outcomes in ER Breast Cancer | OncLive
Dr Kaklamani on the Effects of VAF on Elacestrant Outcomes in ER Br…
Dec 11, 2024
onclive.com
The Role of Elacestrant in Breast Cancer | OncLive
The Role of Elacestrant in Breast Cancer | OncLive
Jan 30, 2024
onclive.com
Real-World Data: Elacestrant for ESR1m, ER , HER2- MBC | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Real-World Data: Elacestrant for ESR1m, ER , HER2- MBC | Targete…
7 months ago
targetedonc.com
Dr. Lin on the Advantage of Elacestrant in ESR1-Mutated Breast Cancer
Dr. Lin on the Advantage of Elacestrant in ESR1-Mutated Brea…
Jun 14, 2022
onclive.com
Considering Elacestrant in ESR1 Breast Cancer After CDK4/6 Inhibi…
11 months ago
targetedonc.com
The EMERALD Trial: Elacestrant Mechanism of Action, Study Desig…
Nov 9, 2022
targetedonc.com
ADELA Study - Elacestrant Everolimus vs. Elacestrant in ER /…
301 views8 months ago
vumedi.com
Real-World Data Reveal Longer PFS With Elacestrant in Breast Cancer …
10 months ago
targetedonc.com
Elacestrant Targeted Therapy for ER /HER2– Metastatic Breast Cancer: …
Jul 3, 2024
targetedonc.com
1:44
Dr Rugo on Elacestrant-Based Combinations in ER /HER2– Metas…
Dec 11, 2024
onclive.com
ER metastatic breast cancer: Key insights on elacestrant from the la…
10 months ago
apple.com
EMERALD: Elacestrant in ER /HER2- Advanced Breast Cancer | OncLive
Jan 23, 2024
onclive.com
Dr. Bardia on Elacestrant in ER /HER2– Metastatic Breast Cancer …
Dec 8, 2022
onclive.com
6:07
Elacestrant real-world progression-free survival (rwPFS) of adult patie…
Dec 18, 2024
onclive.com
Tumore: elacestrant nuova terapia in aiuto a pazienti con carcinoma …
Jun 20, 2024
Il Sole 24 ORE
Dr. Bidard on the FDA Approval of Elacestrant in ER /HER2– Metastat…
Feb 8, 2023
onclive.com
EMERALD subgroup analysis: Elacestrant in endocrine-sensitiv…
Nov 25, 2024
targetedonc.com
0:50
FDA approves Elacestrant (Orserdu) for ER-positive, HER2-negative, E…
1.2K viewsJan 29, 2023
YouTubemedXclusive Learning
Kaklamani on Elacestrant for CDK4/6 Inhibitor-Naive ER Breast …
Dec 12, 2024
targetedonc.com
9:11
Perspectives on a Patient with ESR1m and PIK3CA Mutations
2 weeks ago
YouTubeORSERDU® (elacestrant) HCP
Elacestrant in mBC: EMERALD Trial Insights
4 months ago
vumedi.com
2:35
Dr Lloyd on the Effects of ESR1 Mutations on Elacestrant Outcom…
269 viewsDec 13, 2024
YouTubeOncLive
Imlunestrant vs Elacestrant: MOA and Clinical Trial Differences | On…
4 months ago
oncnursingnews.com
20:05
ESR1 Mutation: The Need for & Role of Testing in ER+/ HER2- Advance…
941 viewsSep 21, 2023
YouTubeCOR2ED The Heart of Medical Education
Advanced HR+ BC: Elacestrant vs. ET, Alpelisib/Inavolisib for PIK3CA…
284 viewsMar 4, 2024
vumedi.com
0:57
Dr Kaklamani on the Effects of VAF on Elacestrant Outcomes in ER+ B…
91 viewsDec 11, 2024
YouTubeOncLive
8:53
Elacestrant in ER+/HER2- mBC with ESR1-mut tumors: Overview of th…
2.9K views9 months ago
YouTubeCOR2ED The Heart of Medical Education
See more videos
Static thumbnail place holder